ClinicalTrials.govpublic full text
Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)
carcinoma, hepatocellular, hepatocellular carcinoma, advanced solid, malignant tumour, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900716
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.